Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Enya Vermeulen

Enya Vermeulen

MSc student
Targeted combination therapies for BCL-2-dependent neuroblastoma patients
Phone 088 97 27 678

This research project is aimed at examining Venetoclax combination strategies for two subgroups of BCL-2-dependent neuroblastoma patients. The first study is focused on finding the best therapy for patients with additional ALK mutations and in the second study we aim at finding a treatment strategy that can help in overcoming MCL-1-mediated Venetoclax resistance